Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
No Takers For Biogen’s Biosimilars Business?
Firm Suggests It Could Retain Biosimilars Unit Amid Lack Of ‘Acceptable’ Offers
Apr 26 2024
•
By
Dave Wallace
Suitors do not appear ready to smash open the piggy bank for Biogen • Source: Shutterstock
More from Deals
More from Business